DexCom, Inc.
DXCM Real Time Price USD$DXCM is featured in our Tina Smith strategy.
See All StrategiesRecent trades of DXCM by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by DXCM's directors and management
Government lobbying spending instances
-
$130,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$170,000 Sep 06, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$160,000 Sep 06, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$56,500 Jan 03, 2024 Issue: Medicare/Medicaid Health Issues
-
$56,500 Oct 19, 2023 Issue: None
-
$67,450 Jul 12, 2023 Issue: Medicare/Medicaid
-
$62,000 Jan 10, 2023 Issue: Health Issues
-
$56,500 Oct 12, 2022 Issue: Economics/Economic Development Medicare/Medicaid
-
$57,000 Jul 12, 2022 Issue: Health Issues
-
$57,000 May 05, 2022 Issue: Medicare/Medicaid Health Issues
-
$57,000 Mar 23, 2022 Issue: Medicare/Medicaid Health Issues
-
$57,000 Oct 05, 2021 Issue: None
-
$57,000 Jul 02, 2021 Issue: None
-
$58,600 Apr 14, 2021 Issue: None
-
$56,274 Jan 08, 2021 Issue: HEALTH ISSUES
-
$57,250 Oct 19, 2020 Issue: MEDICARE/MEDICAID
-
$58,600 Jul 13, 2020 Issue: MEDICARE/MEDICAID
-
$58,632 Apr 13, 2020 Issue: None
-
$57,250 Jan 10, 2020 Issue: None
-
$56,274 Oct 08, 2019 Issue: Health Issues Medicare/Medicaid
-
$52,675 Jul 12, 2019 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 22, 2019 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jan 22, 2019 Issue: Medicare/Medicaid Health Issues
-
$30,000 Oct 19, 2018 Issue: Medicare/Medicaid Health Issues
-
$30,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues
-
$180,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues
-
$250,000 Apr 19, 2018 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 19, 2018 Issue: Medicare/Medicaid Health Issues
-
$7,651 Jan 16, 2018 Issue: Health Issues Medicare/Medicaid
-
$9,700 Oct 23, 2017 Issue: Medicare/Medicaid
-
$6,750 Jul 21, 2017 Issue: Health Issues
-
$8,375 Jul 21, 2017 Issue: Health Issues
-
$80,000 Jul 18, 2017 Issue: Medicare/Medicaid Health Issues
-
$130,000 Apr 20, 2017 Issue: Health Issues Medicare/Medicaid
-
$25,650 Jan 23, 2017 Issue: Health Issues
-
$120,000 Jan 23, 2017 Issue: Medicare/Medicaid Health Issues
-
$12,750 Oct 20, 2016 Issue: Health Issues
-
$150,000 Oct 17, 2016 Issue: Medicare/Medicaid Health Issues
-
$130,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues
-
$36,000 Jul 20, 2016 Issue: Health Issues
-
$36,000 Apr 20, 2016 Issue: Health Issues
-
$20,000 Apr 19, 2016 Issue: Health Issues
-
$70,000 Jan 15, 2016 Issue: Health Issues
-
$70,000 Oct 14, 2015 Issue: Health Issues
-
$60,000 Jul 16, 2015 Issue: Health Issues
-
$50,000 Apr 18, 2015 Issue: Health Issues
-
$20,000 Jan 18, 2015 Issue: Health Issues
-
$40,000 Oct 16, 2014 Issue: Health Issues
-
$60,000 Jul 17, 2014 Issue: Health Issues
-
$20,000 Apr 20, 2014 Issue: Health Issues
-
$40,000 Aug 12, 2007 Issue: Health Issues
-
$100,000 Feb 09, 2007 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Dynamic patient health information sharing Dec. 03, 2024
-
Patent Title: Combination medical device receiver and display Dec. 03, 2024
-
Patent Title: Adaptive interface for continuous monitoring devices Nov. 26, 2024
-
Patent Title: Transcutaneous analyte sensor applicator Nov. 26, 2024
-
Patent Title: Pre-connected analyte sensors Nov. 19, 2024
-
Patent Title: Evaluation and visualization of glycemic dysfunction Nov. 19, 2024
-
Patent Title: Preconnected analyte sensors Nov. 19, 2024
-
Patent Title: Continuous analyte monitoring system power conservation Nov. 19, 2024
-
Patent Title: System and method for mode switching Nov. 19, 2024
-
Patent Title: System and method for mode switching Nov. 19, 2024
-
Patent Title: Continuous analyte monitor data recording device operable in a blinded mode Nov. 19, 2024
-
Patent Title: Diabetes management partner interface for wireless communication of analyte data Nov. 12, 2024
-
Patent Title: Time averaged basal rate optimizer Nov. 12, 2024
-
Patent Title: Systems and methods for distributing continuous glucose data Nov. 05, 2024
-
Patent Title: Preconnected analyte sensors Oct. 29, 2024
-
Patent Title: Systems and methods for enhanced wireless communications between analyte sensor systems and display devices Oct. 22, 2024
-
Patent Title: Systems and methods for processing and transmitting sensor data Oct. 22, 2024
-
Patent Title: Integrated delivery device for continuous glucose sensor Oct. 15, 2024
-
Patent Title: Analyte sensor with impedance determination Oct. 15, 2024
-
Patent Title: Display screen or portion thereof with a graphical user interface Oct. 08, 2024
-
Patent Title: Integrated medicament delivery device for use with continuous analyte sensor Oct. 01, 2024
-
Patent Title: Sensors for continuous analyte monitoring Sep. 17, 2024
-
Patent Title: System and method for activating an analyte monitoring system Sep. 10, 2024
-
Patent Title: Systems and methods for processing and transmitting sensor data Sep. 03, 2024
-
Patent Title: Dynamic report building Sep. 03, 2024
-
Patent Title: Wearable apparatus for continuous blood glucose monitoring Aug. 27, 2024
-
Patent Title: Systems and methods for a continuous monitoring of analyte values Aug. 27, 2024
-
Patent Title: Methods for providing an alert or an alarm to a user of a mobile communications device Aug. 20, 2024
-
Patent Title: Medical device electronic module Aug. 13, 2024
-
Patent Title: Base for medical device electronic module Aug. 13, 2024
-
Patent Title: Systems and methods for processing analyte sensor data Aug. 06, 2024
-
Patent Title: Fault discrimination and responsive processing based on data and context Jul. 30, 2024
-
Patent Title: Evaluation of data to provide decision support for a ketogenic lifestyle Jul. 30, 2024
-
Patent Title: Diabetes management partner interface for wireless communication of analyte data Jul. 23, 2024
-
Patent Title: Wearable medical monitoring device Jul. 23, 2024
-
Patent Title: Systems and methods for technical support of continuous analyte monitoring and sensor systems Jul. 09, 2024
-
Patent Title: Analyte sensor with impedance determination Jul. 09, 2024
-
Patent Title: Systems and methods for technical support of continuous analyte monitoring and sensor systems Jun. 25, 2024
-
Patent Title: Intermittent monitoring Jun. 25, 2024
-
Patent Title: Transcutaneous analyte sensor Jun. 25, 2024
-
Patent Title: Systems and methods for managing glycemic variability Jun. 18, 2024
-
Patent Title: Analyte sensor Jun. 18, 2024
-
Patent Title: Method of making a sensor device Jun. 18, 2024
-
Patent Title: Sensor holder device for invasive biosensors Jun. 11, 2024
-
Patent Title: Detection of anomalous computing environment behavior using glucose Jun. 04, 2024
-
Patent Title: Membrane for continuous analyte sensors Jun. 04, 2024
-
Patent Title: Intermittent monitoring Jun. 04, 2024
-
Patent Title: Systems and methods for processing and transmitting sensor data May. 28, 2024
-
Patent Title: Transcutaneous analyte sensor systems and methods May. 28, 2024
-
Patent Title: Decision support and treatment administration systems May. 21, 2024
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of DXCM in WallStreetBets Daily Discussion
Recent insights relating to DXCM
Recent picks made for DXCM stock on CNBC
ETFs with the largest estimated holdings in DXCM
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view DXCM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.